Table 2.

Effects of Antiasialo GM1 and Anti–NK 1.1 Antibodies on IL-12 Regulation of Angiogenesis In Vivo

Additions to Matrigel Surface Area Occupied by Cells (μm2/1.26 × 105 μm2) (±SD) Inhibition (%)
BALB/c nude 
 None  484 (±179)  —  
 bFGF  9,329 (±1,476) —  
 bFGF + IL-12  2,989 (±638)  67.9 
 bFGF + antiasialo GM1  10,269 (±2,302)  — 
 bFGF + IL-12 + antiasialo GM1  8,638 (±1,688)   7.4 
B57BL/6 nude  
 None  565 (±89)  —  
 bFGF 13,472 (±1,118)  —  
 bFGF + IL-12  3,112 (±389) 76.9  
 bFGF + anti–NK 1.1  12,363 (±3,347)  — 
 bFGF + IL-12 + anti–NK 1.1  10,361 (±604)  2.3 
Additions to Matrigel Surface Area Occupied by Cells (μm2/1.26 × 105 μm2) (±SD) Inhibition (%)
BALB/c nude 
 None  484 (±179)  —  
 bFGF  9,329 (±1,476) —  
 bFGF + IL-12  2,989 (±638)  67.9 
 bFGF + antiasialo GM1  10,269 (±2,302)  — 
 bFGF + IL-12 + antiasialo GM1  8,638 (±1,688)   7.4 
B57BL/6 nude  
 None  565 (±89)  —  
 bFGF 13,472 (±1,118)  —  
 bFGF + IL-12  3,112 (±389) 76.9  
 bFGF + anti–NK 1.1  12,363 (±3,347)  — 
 bFGF + IL-12 + anti–NK 1.1  10,361 (±604)  2.3 

Mice (BALB/c or C57BL/6 nudes) were injected subcutaneously with Matrigel alone, Matrigel + bFGF, Matrigel + bFGF + IL-12, or Matrigel + bFGF + IL-12 + rabbit antiasialo GM1 (BALB/c mice) or anti–NK 1.1 (C57BL/6 mice) antibodies. The mice injected with Matrigel containing antiasialo GM1 or anti–NK 1.1 antibodies were also treated with antiasialo GM1 (1 mg/mouse) or anti–NK 1.1 (100 mg/mouse) antibodies IP, 1 day before as well as 3 days after Matrigel injection. The results reflect the mean (±SD) surface area occupied by cells (μm2 area/1.26 × 105 μm2area) from 12 to 15 fields in each Matrigel plug, 5 Matrigel plugs/group; 4 independent experiments with antiasialo GM1 and 1 experiment with anti–NK 1.1 were performed. Determinations of surface area were performed by a semiautomated digitized analyzer.

or Create an Account

Close Modal
Close Modal